Children With Neurological, Neuromuscular Diseases and Flu


Children with neurological and neuromuscular diseases should receive an annual influenza vaccination because of a higher risk of respiratory failure if they are hospitalized with influenza, according to a study in the Nov. 2, 2005 issue of JAMA.

Influenza is a common disease of childhood and is responsible for significant illness, according to background information in the article. Healthy young children are hospitalized for influenza-related illness at rates similar to those for elderly persons and adults with chronic medical conditions. Perhaps most concerning to parents and physicians is the potential for serious influenza-associated complications, including carditis, encephalitis, myositis, pneumonia, respiratory failure, and death.

Population-based studies suggest that individuals with certain chronic medical conditions are at increased risk of serious complications of influenza infection. The Advisory Committee on Immunization Practices (ACIP) has identified nine groups of chronic medical conditions for which annual influenza vaccination is recommended. They include asthma, chronic lung disease, cardiac disease, immunosuppression, hemoglobinopathies, chronic renal dysfunction, metabolic and endocrine conditions, long-term salicylate therapy, and pregnancy. Despite the frequency of influenza infection and the prevalence of these chronic medical conditions, little is known about their relative contribution to the development of serious influenza-associated complications.

Ron Keren, MD, MPH, of the Childrens Hospital of Philadelphia, and colleagues conducted a study to identify chronic medical conditions that were associated with respiratory failure in children hospitalized with influenza. In addition to the current ACIP-designated high-risk conditions, the researchers also examined three other categories of chronic medical conditionsneurological and neuromuscular disease (NNMD, such as muscular dystrophy), gastroesophageal reflux disease (GERD), and history of prematurity, that in recent studies have been associated with influenza hospitalization and severe influenza-related complications. The study included patients aged 21 years or younger hospitalized at The Childrens Hospital of Philadelphia, with community-acquired laboratory-confirmed influenza during four consecutive influenza seasons (June 2000 through May 2004).

Of 745 children hospitalized with influenza, 322 (43 percent) had one or more ACIP-designated high-risk chronic medical conditions. NNMD, GERD, and history of prematurity were present in 12 percent, 14 percent, and 3 percent, of children, respectively. Thirty-two children (4.3 percent) developed respiratory failure. In further analyses, conditions associated with respiratory failure included NNMD (6 times increased risk), chronic pulmonary disease other than asthma (4.8 times increased risk), and cardiac disease (4 times increased risk). The predicted probabilities of respiratory failure derived from the multivariate model were 12 percent, 9 percent, and 8 percent for children with NNMD, chronic pulmonary disease, and cardiac disease, respectively. Children hospitalized with influenza who had two of these three chronic conditions had a 31 percent to 39 percent predicted probability of respiratory failure.

The significantly increased probability of respiratory failure in children with NNMD hospitalized with influenza supports the ACIPs recent decision to add NNMD that may compromise respiratory function to the list of chronic conditions that warrant annual influenza vaccination. Coordinated efforts are needed to educate parents, primary care pediatricians, and pediatric neurologists about the risks of serious influenza complications and the need for annual vaccination for children with NNMD. Future studies should determine the risk of hospitalization among children with NNMD, the number of additional children with NNMD who will require annual vaccination, as well as the effectiveness and cost-effectiveness of the influenza vaccine in preventing hospitalizations and serious complications in these children, the authors conclude.

Reference: JAMA.2005; 294:2188-2194

Source: American Medical Association

Related Videos
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
COVID-19 germs, fungi, bacteria objects. (Adobe Stock 584704860 by chawalit)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Related Content